SCHEMBL1780225

SCHEMBL1780225

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCN(C)CC3)cc2[N+](=O)[O-])c2cc(C(=O)NC(C)(C)c3ccccc3F)sc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT6 Q8N6T7 6/20 0.39
BTK Q06187 1/20 0.39
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38
AURKA O14965 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
PDE7A Q13946 3/20 0.35
KIT P10721 1/20 0.35
FLT3 P36888 1/20 0.35
WDR5 P61964 2/20 0.34
INSR P06213 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779035 0.92 ABL1 (0.47) SIRT6BTKABL1BCRAURKA
SCHEMBL1779183 0.90 ALK (0.42) BTKABL1BCRAURKAMEN1
SCHEMBL1780753 0.88 ALDH1A1 (0.41) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL1781045 0.87 SIRT6 (0.42) SIRT6BTKALDH1A1MAPK1LMNA
SCHEMBL1779011 0.86 IGF1R (0.43) SIRT6BTKABL1BCRAURKA
SCHEMBL1777733 0.86 SIRT6 (0.40) SIRT6BTKMEN1KMT2AALDH1A1
SCHEMBL1778668 0.85 PDE7A (0.41) BTKABL1BCRAURKAMEN1
Trifluoroacetic Acid SCHEMBL1777732 0.85 SIRT6 (0.41) SIRT6BTKALDH1A1MAPK1LMNA
SCHEMBL1777980 0.85 AURKA (0.40) SIRT6BTKABL1BCRAURKA
SCHEMBL1778613 0.85 BTK (0.40) BTKABL1BCRAURKAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP disclosed
US-7943654-B2 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-17 US disclosed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US disclosed
EP-1904503-A1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-04-02 EP disclosed
WO-2007009898-A1 1H-THIENO[2,3-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors CCNH, PDK1, MAP3K5 SIRT6 2252/4885BTK 940/4885ABL1 397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.